Colgate-Palmolive Company (NYSE:CL) Shares Acquired by Apollon Wealth Management LLC

Apollon Wealth Management LLC lifted its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 17.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,616 shares of the company's stock after purchasing an additional 4,299 shares during the period. Apollon Wealth Management LLC's holdings in Colgate-Palmolive were worth $2,775,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the business. Sigma Planning Corp grew its stake in Colgate-Palmolive by 14.1% during the 1st quarter. Sigma Planning Corp now owns 6,795 shares of the company's stock valued at $637,000 after acquiring an additional 839 shares in the last quarter. Edgestream Partners L.P. acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $1,854,000. Isthmus Partners LLC increased its holdings in shares of Colgate-Palmolive by 1.7% in the first quarter. Isthmus Partners LLC now owns 137,111 shares of the company's stock valued at $12,847,000 after purchasing an additional 2,354 shares during the last quarter. LRI Investments LLC grew its holdings in shares of Colgate-Palmolive by 3.8% in the first quarter. LRI Investments LLC now owns 5,644 shares of the company's stock valued at $529,000 after purchasing an additional 207 shares during the period. Finally, Secured Retirement Advisors LLC grew its holdings in shares of Colgate-Palmolive by 564.3% during the 1st quarter. Secured Retirement Advisors LLC now owns 20,406 shares of the company's stock worth $1,912,000 after purchasing an additional 17,334 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.6%

Shares of NYSE:CL traded down $0.52 on Wednesday, hitting $87.63. 4,197,968 shares of the company's stock were exchanged, compared to its average volume of 4,854,217. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. Colgate-Palmolive Company has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a market capitalization of $71.01 billion, a PE ratio of 24.75, a P/E/G ratio of 4.70 and a beta of 0.37. The firm's 50-day moving average is $90.53 and its 200 day moving average is $90.46.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The business had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter in the prior year, the business posted $0.86 EPS. The company's revenue for the quarter was down 3.0% on a year-over-year basis. Sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.37%. Colgate-Palmolive's dividend payout ratio is presently 58.76%.

Colgate-Palmolive announced that its board has authorized a stock buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's management believes its shares are undervalued.

Analyst Ratings Changes

Several brokerages recently issued reports on CL. Citigroup boosted their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday, April 28th. UBS Group upped their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Barclays lifted their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a report on Tuesday. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. Finally, Piper Sandler dropped their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research note on Monday, March 31st. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of "Hold" and an average target price of $101.20.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.